Peregrine Ventures
VC Fund
Or Yehuda, Israel
Peregrine Ventures is a VC fund in Or Yehuda focused on Health Care and Medical Device. Peregrine Ventures, a leading healthcare fund based in Israel, is committed to improving patients' quality of life by investing in and supporting game-changing healthcare opportunities. As a global life science venture capital fund, Peregrine invests throughout a company’s life cycle to help facilitate growth and success and offers creativebusiness solutions to suit the needs of its portfolio companies. From seed-stage opportunities to more mature companies, Peregrine’s specifically defined funds offer portfolio companies complete, end-to-end investment solutions that have helped bring healthcare innovations to fruition for over 20 years. Peregrine’s robust portfolio includes first and best-in-class global companies, in the fields of biotech, medical devices, and digital health. Peregrine’s mature funds maintain their strong position in the upper quartile of the industry’s leading benchmarks .
- Total investments:
- 180
- Last investment:
- Lead investor:
- 5%
- Fund size:
- $30M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Peregrine Ventures invests in
Stages Peregrine Ventures invests in
Countries Peregrine Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Amit Talia Alfasi
|
|||
Boaz Lifschitz
|
|||
David Eldar
|
|||
Elazer Edelman
|
|||
| See all 10 contacts → | |||
Investment Focus
Industry
- Health Care 42 (23%)
- Medical Device 29 (16%)
- Biotechnology 23 (13%)
- Medical 22 (12%)
- Software 13 (7%)
Stage
- Seed 51 (28%)
- Venture - Series Unknown 26 (14%)
- Series A 20 (11%)
- Series B 11 (6%)
- Pre-Seed 10 (6%)
Country
- Israel 70 (39%)
- United States 8 (4%)
- Ghana 1 (1%)
- Canada 1 (1%)
- Australia 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Amit Talia Alfasi
Marketing Communications and Investor Relations
|
Marketing Communications and Investor Relations | Total investments: 0 | Find email | |
|
Boaz Lifschitz
Managing General Partner & Co-Founder
|
Managing General Partner & Co-Founder | Total investments: 2 | Find email | |
Bryce Butler
Director
|
Director | Total investments: 2 | Find email | |
|
David Eldar
Venture Partner, CFO
|
Venture Partner, CFO | Total investments: 0 | Find email | |
|
Elazer Edelman
Chairman of the medical advisory board
|
Chairman of the medical advisory board | Total investments: 0 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Snipe Medical
|
Snipe Medical is a startup company, developing a novel solution to treat lung cancer. | Series A / Feb 05, 2026 | |
Ionara Bio
|
Ionara Bio is a biotech company that develops drugs for inflammatory responses. | Seed / Feb 01, 2026 | |
|
Stealth mode company
|
This company is currently operating in stealth mode.' | Seed / Feb 01, 2026 | |
Hairstetics
|
Hairstetics is a Health Care company. | Series A / Jan 03, 2026 | |
KAHR medical
|
KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders. | $22M / Series B / Oct 15, 2025 | |
Terrapeutics Pharma
|
Terrapeutics Pharma develops a drug discovery platform that is based on a groundbreaking technology. | $725.8K / Seed / Oct 01, 2025 | |
|
BioRefine
|
Medical device company treating the mitral valve | $500K / Seed / Oct 01, 2025 | |
Raziel Therapeutics
|
Raziel's drug aims for fat melting by harnessing the body’s own natural healing power and delivering proven biological activity. | $212K / Venture - Series Unknown / Oct 01, 2025 | |
Aluma
|
Aluma is an endovascular company developing catheter integrated laser systems for precise treatment of small artery disease. | $780.8K / Seed / Oct 01, 2025 | |
Cordio Medical
|
CORDIO Medical provides groundbreaking solution | $1.3M / Venture - Series Unknown / Oct 01, 2025 | |
| See all 180 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Peregrine Ventures invest in?
Peregrine Ventures invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Seed and Venture - Series Unknown stage. Most of the 180 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Peregrine Ventures?
Public channels for Peregrine Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Peregrine Ventures?
The team at Peregrine Ventures includes Amit Talia Alfasi (Marketing Communications and Investor Relations), Boaz Lifschitz (Managing General Partner & Co-Founder) and Bryce Butler (Director), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
